Ameritox to Present Clinical Research to Forensic Toxicology Scientific Community

BALTIMORE, Oct. 23, 2014 /PRNewswire/ -- Ameritox^SM, the nation's leader in medication monitoring solutions, today announced a strong presence at this week's annual meeting of the Society of Forensic Toxicologists in Grand Rapids, Michigan.

Logo - http://photos.prnewswire.com/prnh/20141022/153846LOGO

The Society of Forensic Toxicologists (SOFT) is a professional organization that helps further the promotion and development of forensic toxicology, the use of toxicology – the study of adverse effects of drugs and chemicals on biological systems – in legal investigations involving poisoning and drug use. The SOFT annual meeting provides opportunities for those in the field to discuss research and trends.

"We are extremely proud of our scientists and the contributions that they make both to our company and to the field as a whole," said Scott Walton, CEO of Ameritox.

"The research that we are presenting this week demonstrates the amount of scientific exploration that is the foundation of every test result that comes out of our laboratory," said Jay Zimmerman, Senior Vice President and Chief Laboratory Officer. "Our company was founded on strong science, and we are proud to grow our industry and advance the science of toxicology."

Ameritox scientists will lead a workshop at the SOFT annual meeting titled: "Rapid Urine Drug Testing by Mass Spectrometry," and will present in the form of medical posters the following clinical research:

• "Development of a Fast Direct Injection TOF-MS Screen for Common Prescription and Non-Prescription Drugs in Urine." Authors: Erin C. Strickland, Jeremy Smith and Gregory L. McIntire.
• "Oral Fluid Testing for Opiates by 'Dilute and Shoot' LC-MS/MS." Authors: Jeffrey R. Enders, Ayodele A. Morris and Gregory L. McIntire.
• "Cross-Platform Comparison of Rapid Benzodiazepine Analyses." Authors: Jennifer C. Hitchcock, Jeremy P. Smith, Jeffrey R. Enders, and Gregory L. McIntire.
• "Buprenorphine Hydrolysis using a Novel Recombinant Beta-Glucuronidase for Urine Drug Testing." Authors: Ayodele A. Morris, Scot A. Chester, Erin C. Strickland and Gregory L.  McIntire.
• "Opiate Hydrolysis by a Novel Recombinant Beta-Glucuronidase for Urinalysis." Authors: Ayodele A. Morris, Scot A. Chester, Erin C. Strickland and Gregory L. McIntire.
• "Barbiturates in 2013: A Pain Medication Monitoring Perspective." Authors: Ayodele A. Morris and Gregory L. McIntire.

For more information about SOFT and its annual meeting, visit www.soft-tox.org.

About Ameritox
Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse, and diversion. As the nation's trusted leader in Pain Medication Monitoring Solutions^SM, Ameritox provides medical and business professionals with health care solutions that can help improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has 800 employees nationwide and laboratory facilities in Greensboro, N.C.

Visit the Ameritox website at: www.ameritox.com 
Follow Ameritox on Twitter: www.twitter.com/ameritox  
Watch Ameritox on YouTube: www.youtube.com/ameritox

Contact: 
Lon Wagner
Director of Communications, Ameritox 
(336) 387-7742 
Email

Genevieve Rozansky 
30 Point Strategies 
202-509-0794 
Email

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/ameritox-to-present-clinical-research-to-forensic-toxicology-scientific-community-413496725.html

SOURCE Ameritox

Related Links

http://www.ameritox.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED